Pathogenesis, Prognosis, Prediction and Personalized Therapy in Breast Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Pathophysiology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 3160
Special Issue Editor
Special Issue Information
Dear Colleagues,
In recent years, traditional prognostic factors in breast cancer such as tumor size and nodal involvement in EBC and disease localization in MBC have lost a lot of their relevance in decision making. Prognostic factors such as HER2neu overexpression, proliferation measured by Ki67 statically and dynamically, and mutation sets in cfDNA, as well as predictive markers such as the aforementioned and PD-L1, PIK3CA mutation status, ESR1 mutation status, and many more have gained importance. This development has just begun to unfold, and diagnostic tools such as next-generation sequencing and investigation of the tumor microenvironment are the next step in this direction of personalized approaches. As we learn more about the biology of breast cancer, this also affects our view of how breast cancer is developing and why, initially, local breast cancer becomes a systemic disease. This Special Issue covers the spectrum from pathogenesis and the development of metastases over prognosis to prediction in early and metastatic breast cancer and includes manuscripts from pathologists, biologists, and breast oncologists.
Prof. Dr. Hans-Christian Kolberg
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- pathogenesis
- prognostic factors
- predictive factors
- liquid biopsy
- multigene assay
